News
Lakshmi Priya Darshini Pulavarthi blends scientific expertise with data management to drive clinical trial success across oncology, hematology, and cardiovascular therapeutic areas.
6d
Live Science on MSNAcne vaccine: Experimental shot for common skin condition reaches clinical trials. Here's what you need to know.An experimental vaccine for acne could someday transform the way patients with the condition are treated, according to the ...
Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...
Selected in the bioprocessing category, Dr. Narain is honored for his pioneering work at the intersection of biology, AI, and translational medicine. Under his leadership, BPGbio has focused on ...
Verastem will launch a U.S. phase 1/2a trial of oral KRAS G12D inhibitor VS-7375 after FDA IND clearance, with data to be ...
BDC-3042 showed biological activity, with clear dose-dependent increases in proinflammatory cytokines and chemokines BDC-3042 showed signs of anti-tumor activity, including an unconfirmed partial ...
17h
Clinical Trials Arena on MSNNeurocrine begins Phase III programme for schizophrenia treatmentThe primary goal of the trial is to measure the decrease in the Positive and Negative Syndrome Scale from baseline.
Members of Disc’s leadership team will review the therapeutic rationale for DISC-0974, summarize clinical data from the Phase 1b trial of DISC-0974 in MF anemia originally presented at the 2024 ...
2d
IFLScience on MSNSperm-Blocking Male Contraceptive Could Hit The Market "As Soon As 2028" After Promising 2-Year Trial ResultsThe injectable hydrogel, administered within a 30-minute appointment, prevents sperm movement without blocking ejaculation or ...
Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical stage biopharmaceutical company, announces it will be presenting at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting to be ...
AACR conference chairs Lillian L. Siu, MD, and Matthew Vander Heiden, MD, PhD, share their perspectives on the event with GEN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results